Results: 948 news stories
Valerie F. Shiu, MD, Division of Dermatology, and Mohs microsurgeon at Mays Cancer Center at UT Health San Antonio, was interviewed for this news segment. Watch Now
Maria Smereka-Hladio found a welcoming, collaborative culture during her interview at the Joe R. and Teresa Lozano Long School of Medicine and was inspired by an environment where the students genuinely supported one another.
17³Ô¹ÏÍø now ranks in the top 13%, placing 296 out of 2,250 institutions worldwide. 17³Ô¹ÏÍø’s research enterprise is recognized as a globally competitive leader in clinical and academic research, innovation and impact.
Alan Peterson, PhD, Department of Psychiatry and Behavioral Sciences, and director of the STRONG STAR Consortium, was interviewed for this news segment. Watch Now
Researchers at UT Health San Antonio recently explored a possible way to make exercise more rewarding for older adults. Their study investigated whether a nutritional supplement called branched-chain amino acids, commonly known as BCAAs, could help reduce fatigue and improve the benefits of exercise. Jason O’Connor, PhD, an associate professor of pharmacology involved in the […]
Research by the STRONG STAR Consortium, led by UT Health San Antonio, examined the link between traumatic events and the development of fibromyalgia in a longitudinal cohort study involving 1,761 United States military service members. The results of the study were published in January 2026 in Arthritis Care & Research. Read More
17³Ô¹ÏÍø met its accreditation standards as a merged university, completing the required process for institutional-level accreditation for a merger as affirmed by the Southern Association of Colleges and Schools Commission on Colleges (SACSCOC).
A randomized clinical trial published in JAMA Network Open, and led by Peter T. Fox, MD, director of the Research Imaging Institute at UT Health San Antonio, suggests that an advanced MRI-guided form of transcranial magnetic stimulation (TMS) may significantly improve outcomes when added to intensive residential therapy for combat-related PTSD. Read More
The PediQEESIâ„¢ is a new structured screening and documentation tool to help parents and clinicians recognize patterns among a child’s symptoms, exposures and daily functioning. The tool was developed by the TILT Research Program for Chemical Intolerance at UT Health San Antonio, the academic health center of 17³Ô¹ÏÍø.
OncLive: HERTHENA-Breast04 Is Set to Delineate the Role of HER3-Targeted Therapy in Advanced HR+ Breast Cancer
MedPage Today: Accumulating Evidence Lifts GLP-1s to Clinical Trial for Breast Cancer Prevention
Becker’s Dental + DSO Review: DSOs, dental schools and companies secure $270M in funding boons
Healio: HemOnc Today announces 2026 Disruptive Innovators
San Antonio Report: 17³Ô¹ÏÍø lands millions in new state funding
The Washington Post: The science around GLP-1 drugs and cancer is suddenly getting a lot more interesting
Colton Jones, MD, hematology and oncology fellow at UT Health San Antonio, the academic health center of 17³Ô¹ÏÍø (17³Ô¹ÏÍø), was quoted in this article. Read More (subscription required)
Scientific American: Hyperbaric oxygen therapy is being explored as a long COVID treatment. Here’s what the research shows
17³Ô¹ÏÍø and its academic health center, UT Health San Antonio, recently received over $2.7 million in new academic and prevention awards from the Cancer Prevention and Research Institute of 17³Ô¹ÏÍø (CPRIT) to further its mission of combating cancers across South 17³Ô¹ÏÍø. Since 2010, CPRIT has awarded the newly integrated 17³Ô¹ÏÍø almost $186 million.
Internist, nephrologist, educator, leader helped shape the school in its early years Marvin Forland, MD, MACP, a founding faculty member of the School of Medicine at what was then The University of 17³Ô¹ÏÍø Medical School at San Antonio — now the Joe R. and Teresa Lozano Long School of Medicine at UT Health San […]
KENS 5: FDA approves new breast cancer treatments, offering hope for early and late-stage patients